Skip to ContentSkip to Navigation
About us Latest news News News articles

Dr. El Aidy receives Athena Award from NWO

04 December 2020

Dr. Sahar El Aidy of the Groningen Biomolecular Sciences and Biotechnology Institute ( GBB ) has been awarded the NWO Athena Award. With this award, which is one of five new Science Awards introduced by NWO, El Aidy receives EUR 50,000 towards her research costs. The Athena Award is a prize for outstanding female researchers. In addition to El Aidy, the Award also goes to Prof. Arwen Deuss of Utrecht University.

Dr. El Aidy
Dr. El Aidy

Sahar El Aidy researches into microbiomes, in particular the activity and role of gut metabolites on mental and neurological function in humans. The jury considers Sahar El Aidy to be an excellent role model: “she is a young and talented researcher, she has set up a unique and successful research group, and she has produced ground-breaking publications. She is a high-profile researcher who is very good at communicating about her research.

El Aidy always succeeds in conveying her three core messages: ‘let your food be your medicine’, ‘your gut microbes can influence the efficacy of your medication’, and ‘fundamental research into health and illness is important’.”

Last modified:24 April 2024 2.10 p.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 28 April 2025

    Engineering Smart Decisions for a Dynamic World

    Dynamical systems, i.e. mathematical models that describe how things evolve over time, are at the heart of much of the modern world. The real challenge, however, lies in shaping the systems’ behaviour to achieve a specific goal.

  • 25 April 2025

    Leading microbiologist Arnold Driessen honoured

    On 25 April 2025, Arnold Driessen (Horst, the Netherlands, 1958) received a Royal Decoration. Driessen is Professor of Molecular Microbiology and chair of the Molecular Microbiology research department of the Faculty of Science and Engineering at the...

  • 24 April 2025

    Highlighted papers April 2025

    The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.